SUSQUEHANNA INTERNATIONAL GROUP, LLP - SECOND SIGHT MED PRODS INC ownership

SECOND SIGHT MED PRODS INC's ticker is EYES and the CUSIP is 81362J209. A total of 35 filers reported holding SECOND SIGHT MED PRODS INC in Q4 2021. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q2 2022$145,000
-1.4%
71,300
-30.6%
0.00%
Q1 2022$147,000
-0.7%
102,745
+14.4%
0.00%
Q4 2021$148,000
-83.8%
89,800
-68.7%
0.00%
Q3 2021$916,000
-67.2%
287,115
-49.2%
0.00%
Q2 2021$2,792,000
+71.3%
565,255
+186.2%
0.00%
Q1 2021$1,630,000
+2918.5%
197,520
+266.3%
0.00%
Q1 2020$54,00053,9230.00%
Other shareholders
SECOND SIGHT MED PRODS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Altium Capital Management LP 373,867$1,847,0000.43%
NewGen Asset Management Ltd 200,000$988,0000.37%
SABBY MANAGEMENT, LLC 174,900$864,0000.12%
Kepos Capital LP 100,000$494,0000.04%
Hudson Bay Capital Management LP 380,404$1,879,0000.02%
Paloma Partners Management Co 139,081$687,0000.01%
Cutler Group LLC / CA 24,495$121,0000.01%
Cutler Group LLC / CA 35,000$36,0000.00%
Stratos Wealth Partners, LTD. 15,543$77,0000.00%
Lake Point Wealth Management 1,000$5,0000.00%
View complete list of SECOND SIGHT MED PRODS INC shareholders